Vascular endothelial growth factor suppresses <scp>TNFSF</scp>15 production in endothelial cells by stimulating miR‐31 and miR‐20a expression via activation of Akt and Erk signals

Huiting Deng, Hailin Liu, Beibei Zhai, Kun Zhang, Guo‐Ce Xu, Xuemei Peng, Qiangzhe Zhang, Lu‐Yuan Li

FEBS Open Bio · 2016 · 27 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

Tumor necrosis factor superfamily‐15 ( TNFSF 15; VEGI ; TL 1A) is a negative modulator of angiogenesis for blood vessel homeostasis and is produced by endothelial cells in a mature vasculature. It is known to be downregulated by vascular endothelial growth factor ( VEGF ), a major regulator of neovascularization but the mechanism of this interaction is unclear. Here we report that VEGF is able to stimulate the production of two micro RNA s, miR‐20a and miR‐31, which directly target the 3′‐ UTR of TNFSF 15. Additionally, we show that two VEGF ‐stimulated cell growth signals, Erk and Akt, are responsible for promoting the expression of miR‐20a and miR‐31. Treatment of human umbilical vein endothelial cells ( HUVEC s) with Akt inhibitor LY 294002 results in diminished miR‐20a and miR‐31 production, while Erk inhibitor U0126 prevented VEGF ‐stimulated expression of miR‐20a but not that of miR‐31. Furthermore, inactivation of either Erk or Akt signals restores TNFSF 15 gene expression. In an angiogenesis assay, elevated miR‐20a or miR‐31 levels in HUVEC s leads to enhancement of capillary‐like tubule formation in vitro , whereas lowered miR‐20a and miR‐31 levels results in an inhibition. These findings are consistent with the view that miR‐20a and miR‐31 mediate VEGF ‐induced downregulation of TNFSF 15. Targeting these micro RNA molecules may therefore provide an effective approach to inhibit angiogenesis.

References

23